ALSN Vol. 16, No. 2
Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Tuesday, March 1, 2011 - 11:15, By: Margaret Wahl
New insights and perspectives on the biology of ALS, best practices in the care of individuals with the disease and future directions for development of ALS therapies were the central themes of the 21st International Symposium on ALS/MND (Motor Neuron Disease) that took place in Orlando, Fla., Dec...
Posted on Tuesday, March 1, 2011 - 10:47, By: ALSN Staff
ALS TDI expansion among 2011 goals
Building on progress made in 2010, the MDA-supported ALS Therapy Development Institute (ALS TDI) has outlined a number of milestones it plans to meet in 2011.
Steve Perrin, ALS TDI chief scientific officer and CEO at the nonprofit biotech in Cambridge, Mass...
Posted on Tuesday, March 1, 2011 - 09:06, By: ALSN Staff
MDA has awarded eight new grants totaling nearly $2.5 million to fund research into the causes of, and potential therapies for, ALS.
The grants were reviewed and approved by the MDA Board of Directors in December 2010, based on recommendations from the MDA Scientific and Medical Advisory Committees...